Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.

Wang BD, Ceniccola K, Hwang S, Andrawis R, Horvath A, Freedman JA, Olender J, Knapp S, Ching T, Garmire L, Patel V, Garcia-Blanco MA, Patierno SR, Lee NH.

Nat Commun. 2017 Jun 30;8:15921. doi: 10.1038/ncomms15921.

2.
3.

African-American and Caribbean-Born Men's Perceptions of Prostate Cancer Fear and Facilitators for Screening Behavior: a Pilot Study.

Cobran EK, Hall JN, Aiken WD.

J Cancer Educ. 2017 Jan 16. doi: 10.1007/s13187-017-1167-x. [Epub ahead of print]

PMID:
28093703
4.

Impact of Age, Race and Socio-economic Status on Temporal Trends in Late-Stage Prostate Cancer Diagnosis in Florida.

Goovaerts P, Xiao H, Gwede CK, Tan F, Huang Y, Adunlin G, Ali A.

Spat Stat. 2015 Nov 1;14(Pt 100):321-337.

5.

The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.

Brewer KC, Peterson CE, Davis FG, Hoskins K, Pauls H, Joslin CE.

Ann Epidemiol. 2015 Aug;25(8):556-63. doi: 10.1016/j.annepidem.2015.03.021. Epub 2015 Apr 18.

6.

Ethnic differences in patients' preferences for prostate cancer investigation: a vignette-based survey in primary care.

Martins T, Ukoumunne OC, Banks J, Raine R, Hamilton W.

Br J Gen Pract. 2015 Mar;65(632):e161-70. doi: 10.3399/bjgp15X683965. Erratum in: Br J Gen Pract. 2015 Jun;65(635):287.

7.

Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.

Xiao H, Tan F, Goovaerts P, Adunlin G, Ali AA, Gwede CK, Huang Y.

Am J Mens Health. 2016 Jul;10(4):285-95. doi: 10.1177/1557988314564593. Epub 2014 Dec 26.

8.

Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.

Moses KA, Chen LY, Sjoberg DD, Bernstein M, Touijer KA.

BMC Urol. 2014 Dec 11;14:98. doi: 10.1186/1471-2490-14-98.

9.

Feasibility Study of Engaging Barbershops for Prostate Cancer Education in Rural African-American Communities.

Luque JS, Roy S, Tarasenko YN, Ross L, Johnson J, Gwede CK.

J Cancer Educ. 2015 Dec;30(4):623-8. doi: 10.1007/s13187-014-0739-2.

10.

Associations between patient-provider communication and socio-cultural factors in prostate cancer patients: a cross-sectional evaluation of racial differences.

Song L, Weaver MA, Chen RC, Bensen JT, Fontham E, Mohler JL, Mishel M, Godley PA, Sleath B.

Patient Educ Couns. 2014 Dec;97(3):339-46. doi: 10.1016/j.pec.2014.08.019. Epub 2014 Sep 4.

11.

Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.

Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Gwede CK, Huang Y.

Am J Mens Health. 2014 Jul;8(4):316-26. doi: 10.1177/1557988313512862. Epub 2013 Dec 1.

12.

Limited PSA testing in indigent men in South Texas: an appropriate care or missing a prevention opportunity?

Liang Y, Du F, Thompson IM, Turner BJ.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1489-96. doi: 10.1158/1055-9965.EPI-12-0497. Epub 2012 Jul 20.

13.

Clinical profile, quality of care, and recurrence in Arab-American and Caucasians prostate cancer patients in Michigan.

Moussawi AH, Yassine M, Dey S, Soliman AS.

J Immigr Minor Health. 2013 Aug;15(4):803-9. doi: 10.1007/s10903-012-9662-y.

14.

Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.

Chornokur G, Dalton K, Borysova ME, Kumar NB.

Prostate. 2011 Jun 15;71(9):985-97. doi: 10.1002/pros.21314. Epub 2010 Dec 28. Review.

15.

Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Wallace TA, Martin DN, Ambs S.

Carcinogenesis. 2011 Aug;32(8):1107-21. doi: 10.1093/carcin/bgr066. Epub 2011 Apr 3. Review.

16.

Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.

White A, Coker AL, Du XL, Eggleston KS, Williams M.

Cancer. 2011 Mar 1;117(5):1080-8. doi: 10.1002/cncr.25671. Epub 2010 Nov 8.

17.

Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.

Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, Jia Z, Lilly MB, De León M, Casiano CA.

Prostate. 2011 May 15;71(7):755-65. doi: 10.1002/pros.21292. Epub 2010 Oct 28.

18.

Copy number and gene expression differences between African American and Caucasian American prostate cancer.

Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB, Yu JZ, Dash A, Jean-Gilles J, Reuter V, Gerald WL, Lee P, Osman I.

J Transl Med. 2010 Jul 22;8:70. doi: 10.1186/1479-5876-8-70.

19.

Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA.

Seo HS, Lee NK.

Korean J Urol. 2010 Jun;51(6):391-7. doi: 10.4111/kju.2010.51.6.391. Epub 2010 Jun 21.

20.

Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999-2001.

Altekruse SF, Huang L, Cucinelli JE, McNeel TS, Wells KM, Oliver MN.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1460-7. doi: 10.1158/1055-9965.EPI-09-1310. Epub 2010 May 25.

Supplemental Content

Support Center